欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SI/H/0172/003
药品名称Meropenem AptaPharma 2000 mg
活性成分
    • Meropenem trihydrate 2280.0 mg
剂型Powder for solution for infusion
上市许可持有人Apta Medica Internacional d.o.o. Likozarjeva ulica 6 1000 Ljubljana Slovenia
参考成员国 - 产品名称Slovenia (SI)
Meropenem AptaPharma 2000 mg prašek za raztopino za infundiranje
互认成员国 - 产品名称
    • Bulgaria (BG)
    • Denmark (DK)
    • Cyprus (CY)
      MEROPENEM APTAPHARM 2000MG POWDER FOR SOLUTION FOR INFUSION
    • Netherlands (NL)
    • Czechia (CZ)
      Meropenem AptaPharma 2000 mg Prášek pro infuzní roztok
    • Sweden (SE)
    • Romania (RO)
      Meropenem AptaPharma 2000 mg pulbere pentru soluție perfuzabilă
    • Malta (MT)
    • Norway (NO)
    • Croatia (HR)
    • Finland (FI)
    • Slovakia (SK)
    • Austria (AT)
    • Poland (PL)
      Meropenem AptaPharma
    • Hungary (HU)
许可日期2022/05/12
最近更新日期2025/01/28
药物ATC编码
    • J01DH02 meropenem
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase